SMART-AML: Shaping Marrow Adiposity to Redefine Treatment in Acute Myeloid Leukemia

Funder	European Commission
Recipient Organization	Universitair Medisch Centrum Utrecht
Country	Netherlands
Start Date	Jan 01, 2025
End Date	Dec 31, 2026
Duration	729 days
Number of Grantees	1
Roles	Coordinator
Data Source	European Commission
Grant ID	`101153517`

Grant Description

Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy characterized by the uncontrolled proliferation of myeloid cells, which hijack the bone marrow (BM) and compromise its physiological functions. AML prognosis remains poor, with